Stocksigma LogoStocksigma Logo

Anondita Medicare Reports Nil Deviation Across Fundraising Proceeds for H1 FY27

Anondita Medicare reported no deviation in fund utilization for the half-year ended 30th Sep'26 across its IPO, Rights Issue, and Preferential Issue

Anondita Medicare Reports Nil Deviation Across Fundraising Proceeds for H1 FY27

Anondita Medicare Ltd · Others (Uncategorized) · 15 Nov 2026, 2:21 am

Anondita Medicare Reports Nil Deviation Across Fundraising Proceeds for H1 FY27 Anondita Medicare reported no deviation in fund utilization for the half-year ended 30th Sep'26 across its IPO, Rights Issue, and Preferential Issue. From its ₹69.50 cr IPO proceeds, ₹37.78 cr was deployed for working capital, ₹17.37 cr for general corporate purposes, ₹6.00 cr for capex, and ₹8.33 cr for issue expenses. The ₹91.03 cr raised via Rights Issue on 24th Sep'26 remained entirely unutilized. Of the ₹29.58 cr Preferential Issue, ₹7.39 cr (25% upfront warrant subscription) was almost fully deployed toward facility expansion.

Original exchange filing (PDF)

More announcements from Anondita Medicare Ltd

All Anondita Medicare Ltd announcements